Gastrointestinal Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
The global Gastrointestinal Therapeutics market size is poised to register 4.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gastrointestinal Therapeutics market across By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).
The gastrointestinal therapeutics market is experiencing steady growth, driven by the rising prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and peptic ulcers, coupled with increasing research and development activities focusing on novel treatment modalities. Gastroenterologists and healthcare providers are leveraging a range of therapeutic options including proton pump inhibitors (PPIs), H2 receptor antagonists, and immunomodulators to manage these conditions and improve patient outcomes. Moreover, advancements in drug delivery systems, personalized medicine approaches, and biologic therapies are further propelling market expansion as stakeholders aim to address the diverse needs of patients with gastrointestinal ailments.
Gastrointestinal Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gastrointestinal Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gastrointestinal Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gastrointestinal Therapeutics industry.
Key market trends defining the global Gastrointestinal Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gastrointestinal Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Gastrointestinal Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gastrointestinal Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gastrointestinal Therapeutics industry
Leading Gastrointestinal Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gastrointestinal Therapeutics companies.
Gastrointestinal Therapeutics Market Study- Strategic Analysis Review
The Gastrointestinal Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Gastrointestinal Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Gastrointestinal Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Gastrointestinal Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Gastrointestinal Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Gastrointestinal Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Gastrointestinal Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gastrointestinal Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gastrointestinal Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Gastrointestinal Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gastrointestinal Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gastrointestinal Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Gastrointestinal Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Gastrointestinal Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gastrointestinal Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gastrointestinal Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gastrointestinal Therapeutics.
Gastrointestinal Therapeutics Market Company Profiles
The global Gastrointestinal Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, AbbVie Inc, AstraZeneca, Bayer AG, Biogen, Cipla Inc, Gilead Sciences Inc, Janssen Pharmaceuticals NV, Organon Group of Companies, Pfizer Inc, Salix Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd
Recent Gastrointestinal Therapeutics Market Developments
The global Gastrointestinal Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gastrointestinal Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Branded
Generics
By Drug Class
Aminosalicylates
Digestive enzymes
Proton Pump Inhibitors
Laxatives
Anti-Emetics
H2 Antagonists
Anti-Diarrheal
Biologics/Biosimilar
Others
By Route of Administration
Oral
Injectable
Others
By Application
Crohn's disease
Ulcerative colitis
GERD
IBS
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
Abbott
AbbVie Inc
AstraZeneca
Bayer AG
Biogen
Cipla Inc
Gilead Sciences Inc
Janssen Pharmaceuticals NV
Organon Group of Companies
Pfizer Inc
Salix Pharmaceuticals
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
Formats Available: Excel, PDF, and PPT
The gastrointestinal therapeutics market is experiencing steady growth, driven by the rising prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and peptic ulcers, coupled with increasing research and development activities focusing on novel treatment modalities. Gastroenterologists and healthcare providers are leveraging a range of therapeutic options including proton pump inhibitors (PPIs), H2 receptor antagonists, and immunomodulators to manage these conditions and improve patient outcomes. Moreover, advancements in drug delivery systems, personalized medicine approaches, and biologic therapies are further propelling market expansion as stakeholders aim to address the diverse needs of patients with gastrointestinal ailments.
Gastrointestinal Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gastrointestinal Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gastrointestinal Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gastrointestinal Therapeutics industry.
Key market trends defining the global Gastrointestinal Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gastrointestinal Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Gastrointestinal Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gastrointestinal Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gastrointestinal Therapeutics industry
Leading Gastrointestinal Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gastrointestinal Therapeutics companies.
Gastrointestinal Therapeutics Market Study- Strategic Analysis Review
The Gastrointestinal Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Gastrointestinal Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Gastrointestinal Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Gastrointestinal Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Gastrointestinal Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Gastrointestinal Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Gastrointestinal Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gastrointestinal Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gastrointestinal Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Gastrointestinal Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gastrointestinal Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gastrointestinal Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Gastrointestinal Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Gastrointestinal Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gastrointestinal Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gastrointestinal Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gastrointestinal Therapeutics.
Gastrointestinal Therapeutics Market Company Profiles
The global Gastrointestinal Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, AbbVie Inc, AstraZeneca, Bayer AG, Biogen, Cipla Inc, Gilead Sciences Inc, Janssen Pharmaceuticals NV, Organon Group of Companies, Pfizer Inc, Salix Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd
Recent Gastrointestinal Therapeutics Market Developments
The global Gastrointestinal Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gastrointestinal Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Branded
Generics
By Drug Class
Aminosalicylates
Digestive enzymes
Proton Pump Inhibitors
Laxatives
Anti-Emetics
H2 Antagonists
Anti-Diarrheal
Biologics/Biosimilar
Others
By Route of Administration
Oral
Injectable
Others
By Application
Crohn's disease
Ulcerative colitis
GERD
IBS
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott
AbbVie Inc
AstraZeneca
Bayer AG
Biogen
Cipla Inc
Gilead Sciences Inc
Janssen Pharmaceuticals NV
Organon Group of Companies
Pfizer Inc
Salix Pharmaceuticals
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Gastrointestinal Therapeutics Market Overview and Key Findings, 2024
1.2 Gastrointestinal Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Gastrointestinal Therapeutics Market Growth Opportunities to 2030
1.4 Key Gastrointestinal Therapeutics Market Trends and Challenges
1.4.1 Gastrointestinal Therapeutics Market Drivers and Trends
1.4.2 Gastrointestinal Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gastrointestinal Therapeutics Companies
2. GASTROINTESTINAL THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Gastrointestinal Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Gastrointestinal Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GASTROINTESTINAL THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Branded
Generics
By Drug Class
Aminosalicylates
Digestive enzymes
Proton Pump Inhibitors
Laxatives
Anti-Emetics
H2 Antagonists
Anti-Diarrheal
Biologics/Biosimilar
Others
By Route of Administration
Oral
Injectable
Others
By Application
Crohn's disease
Ulcerative colitis
GERD
IBS
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gastrointestinal Therapeutics Market, 2025
5.2 Asia Pacific Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gastrointestinal Therapeutics Market, 2025
5.5 Europe Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gastrointestinal Therapeutics Market, 2025
5.8 North America Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gastrointestinal Therapeutics Market, 2025
5.11 South America Pacific Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gastrointestinal Therapeutics Market, 2025
5.14 Middle East Africa Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gastrointestinal Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gastrointestinal Therapeutics Industry Drivers and Opportunities
7. GASTROINTESTINAL THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GASTROINTESTINAL THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Gastrointestinal Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
AbbVie Inc
AstraZeneca
Bayer AG
Biogen
Cipla Inc
Gilead Sciences Inc
Janssen Pharmaceuticals NV
Organon Group of Companies
Pfizer Inc
Salix Pharmaceuticals
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Gastrointestinal Therapeutics Market Overview and Key Findings, 2024
1.2 Gastrointestinal Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Gastrointestinal Therapeutics Market Growth Opportunities to 2030
1.4 Key Gastrointestinal Therapeutics Market Trends and Challenges
1.4.1 Gastrointestinal Therapeutics Market Drivers and Trends
1.4.2 Gastrointestinal Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gastrointestinal Therapeutics Companies
2. GASTROINTESTINAL THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Gastrointestinal Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Gastrointestinal Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GASTROINTESTINAL THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Branded
Generics
By Drug Class
Aminosalicylates
Digestive enzymes
Proton Pump Inhibitors
Laxatives
Anti-Emetics
H2 Antagonists
Anti-Diarrheal
Biologics/Biosimilar
Others
By Route of Administration
Oral
Injectable
Others
By Application
Crohn's disease
Ulcerative colitis
GERD
IBS
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gastrointestinal Therapeutics Market, 2025
5.2 Asia Pacific Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gastrointestinal Therapeutics Market, 2025
5.5 Europe Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gastrointestinal Therapeutics Market, 2025
5.8 North America Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gastrointestinal Therapeutics Market, 2025
5.11 South America Pacific Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gastrointestinal Therapeutics Market, 2025
5.14 Middle East Africa Gastrointestinal Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gastrointestinal Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gastrointestinal Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gastrointestinal Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gastrointestinal Therapeutics Industry Drivers and Opportunities
7. GASTROINTESTINAL THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GASTROINTESTINAL THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Gastrointestinal Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
AbbVie Inc
AstraZeneca
Bayer AG
Biogen
Cipla Inc
Gilead Sciences Inc
Janssen Pharmaceuticals NV
Organon Group of Companies
Pfizer Inc
Salix Pharmaceuticals
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
